Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-024265
Filing Date
2021-06-16
Accepted
2021-06-16 19:27:58
Documents
1
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5105
  Complete submission text file 0000899243-21-024265.txt   6678
Mailing Address WALKER HOUSE 87 MARY STREET GEORGE TOWN E9 KY1-9001
Business Address WALKER HOUSE 87 MARY STREET GEORGE TOWN E9 KY1-9001 212.300.5575
Casdin Partners Master Fund, L.P. (Reporting) CIK: 0001534265 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40489 | Film No.: 211022887

Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations